Hormone Therapy in Treating Women With Breast Cancer
Status:
Completed
Trial end date:
2001-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormone therapy using
arzoxifene hydrochloride may fight breast cancer by blocking the use of estrogen by the tumor
cells.
PURPOSE: This randomized phase II trial is comparing two different doses of arzoxifene
hydrochloride to see how well it works in treating women with advanced or metastatic breast
cancer.